291 related articles for article (PubMed ID: 4251585)
1. [Complications with synthetic antimalarials].
Huriez C; Desmons F; Gautier G; Dhellemmes
Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
[No Abstract] [Full Text] [Related]
2. [Synthetic antimalarials and skin].
Ribrioux A
Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
[No Abstract] [Full Text] [Related]
3. Antimalarials in the management of discoid and systemic lupus erythematosus.
Dubois EL
Semin Arthritis Rheum; 1978 Aug; 8(1):33-51. PubMed ID: 358397
[No Abstract] [Full Text] [Related]
4. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
5. Pigmentation and retinopathy due to chloroquine.
Stewart TW; Miles DW; Earnshaw ER
Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103
[No Abstract] [Full Text] [Related]
6. [Ocular accidents from synthetic antimalarials (apropos of 4 new cases)].
Hermann P; Lefranc E; Sourdille P
Bull Soc Ophtalmol Fr; 1966 Nov; 66(11):1166-76. PubMed ID: 5987464
[No Abstract] [Full Text] [Related]
7. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy.
Truhan AP; Ahmed AR
Ann Allergy; 1989 May; 62(5):375-91. PubMed ID: 2655506
[No Abstract] [Full Text] [Related]
8. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
9. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers.
Rubin M
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735
[No Abstract] [Full Text] [Related]
10. [Side effects of gold salts].
Renier JC; Boasson M
Therapie; 1976; 31(3):365-76. PubMed ID: 136766
[No Abstract] [Full Text] [Related]
11. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
Camus JP; Crouzet J; Prier A; Leca AP
Therapie; 1976; 31(3):385-97. PubMed ID: 136767
[No Abstract] [Full Text] [Related]
12. Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
Vidal D; Altés J; Smandia JA
Actas Dermosifiliogr; 2013 Jan; 104(1):89-90. PubMed ID: 22831783
[No Abstract] [Full Text] [Related]
13. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
[No Abstract] [Full Text] [Related]
14. Ocular toxicity of antimalarial drugs. Long-term follow-up.
Carr RE; Henkind P; Rothfield N; Siegel IM
Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
[No Abstract] [Full Text] [Related]
15. [Effectiveness of butadione ointment in some dermatoses].
Gadzhiev RG; Davardarova MM
Vestn Dermatol Venerol; 1975 Aug; (8):75-7. PubMed ID: 126605
[No Abstract] [Full Text] [Related]
16. [Complications in chloroquin therapy].
Siegmeth W
Acta Med Austriaca; 1975; 2(4):116-21. PubMed ID: 1241500
[TBL] [Abstract][Full Text] [Related]
17. Antimalarials.
Koranda FC
J Am Acad Dermatol; 1981 Jun; 4(6):650-5. PubMed ID: 6165744
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous-mucous toxidermia with synthetic antimalarial drugs].
Gillet P; Gillet-Terver MN; Bannwarth B; Trechot P; Pere P; Netter P; Gaucher A
Therapie; 1991; 46(5):391. PubMed ID: 1836681
[No Abstract] [Full Text] [Related]
19. [Undesired effects of cimetidine: review of the literature].
Del Favero A; Morelli A; Narducci F
Clin Ter; 1981 Jan; 96(1):81-91. PubMed ID: 7016411
[No Abstract] [Full Text] [Related]
20. Current treatment of cutaneous lupus erythematosus.
Werth V
Dermatol Online J; 2001 Feb; 7(1):2. PubMed ID: 11328623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
